TY - JOUR AU - Chopra, A. PY - 2015 DA - 2015// TI - Disease burden of rheumatic diseases in India: COPCORD perspective JO - Indian J Rheumatol VL - 10 UR - https://doi.org/10.1016/j.injr.2015.04.002 DO - 10.1016/j.injr.2015.04.002 ID - Chopra2015 ER - TY - JOUR AU - Davatchi, F. AU - Jamshidi, A. R. AU - Banihashemi, A. T. AU - Gholami, J. AU - Forouzanfar, M. H. AU - Akhlaghi, M. PY - 2008 DA - 2008// TI - WHO-ILAR COPCORD study (stage 1, urban study) in Iran JO - J Rheumatol VL - 35 ID - Davatchi2008 ER - TY - STD TI - Singh JA, Saag KG, Bridges Jr. Sl, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(1):1–26. ID - ref3 ER - TY - JOUR AU - Sadat-Ebrahimi, S. R. AU - Parnianfard, N. AU - Vahed, N. AU - Babaei, H. AU - Ghojazadeh, M. AU - Tang, S. PY - 2018 DA - 2018// TI - An evidence-based systematic review of the off-label uses of lisinopril JO - Br J Clin Pharmacol VL - 84 UR - https://doi.org/10.1111/bcp.13705 DO - 10.1111/bcp.13705 ID - Sadat-Ebrahimi2018 ER - TY - JOUR AU - Barone, M. AU - Notarnicola, A. AU - Lopalco, G. AU - Viggiani, M. T. AU - Sebastiani, F. AU - Covelli, M. PY - 2015 DA - 2015// TI - Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection JO - Hepatology. VL - 62 UR - https://doi.org/10.1002/hep.27716 DO - 10.1002/hep.27716 ID - Barone2015 ER - TY - JOUR AU - Moots, R. J. AU - Naisbett-Groet, B. PY - 2012 DA - 2012// TI - The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review JO - Rheumatology. VL - 51 UR - https://doi.org/10.1093/rheumatology/kes217 DO - 10.1093/rheumatology/kes217 ID - Moots2012 ER - TY - JOUR AU - Rubbert-Roth, A. PY - 2012 DA - 2012// TI - Assessing the safety of biologic agents in patients with rheumatoid arthritis JO - Rheumatology VL - 51 UR - https://doi.org/10.1093/rheumatology/kes114 DO - 10.1093/rheumatology/kes114 ID - Rubbert-Roth2012 ER - TY - JOUR AU - Salvana, E. M. T. AU - Salata, R. A. PY - 2009 DA - 2009// TI - Infectious complications associated with monoclonal antibodies and related small molecules JO - Clin Microbiol Rev VL - 22 UR - https://doi.org/10.1128/CMR.00040-08 DO - 10.1128/CMR.00040-08 ID - Salvana2009 ER - TY - JOUR AU - Hamilton, C. D. PY - 2004 DA - 2004// TI - Infectious complications of treatment with biologic agents JO - Curr Opin Rheumatol VL - 16 UR - https://doi.org/10.1097/01.bor.0000127594.92432.7c DO - 10.1097/01.bor.0000127594.92432.7c ID - Hamilton2004 ER - TY - BOOK AU - Ochoa, C. AU - Rajaram, P. AU - Tanukonda, S. AU - Sadikot, R. T. PY - 2016 DA - 2016// TI - Infectious Complications In Patients Receiving Biologic Therapy. A44 DRUG INDUCED AND RARE LUNG DISEASE: American Thoracic Society ID - Ochoa2016 ER - TY - JOUR AU - Cantini, F. AU - Nannini, C. AU - Niccoli, L. AU - Petrone, L. AU - Ippolito, G. AU - Goletti, D. PY - 2017 DA - 2017// TI - Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics JO - Mediat Inflamm VL - 2017 UR - https://doi.org/10.1155/2017/8909834 DO - 10.1155/2017/8909834 ID - Cantini2017 ER - TY - JOUR AU - Cantini, F. AU - Niccoli, L. AU - Capone, A. AU - Petrone, L. AU - Goletti, D. PY - 2019 DA - 2019// TI - Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice JO - Expert Opin Drug Saf VL - 18 UR - https://doi.org/10.1080/14740338.2019.1612872 DO - 10.1080/14740338.2019.1612872 ID - Cantini2019 ER - TY - JOUR AU - Cantini, F. AU - Nannini, C. AU - Niccoli, L. AU - Iannone, F. AU - Delogu, G. AU - Garlaschi, G. PY - 2015 DA - 2015// TI - Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice JO - Autoimmun Rev VL - 14 UR - https://doi.org/10.1016/j.autrev.2015.01.011 DO - 10.1016/j.autrev.2015.01.011 ID - Cantini2015 ER - TY - JOUR AU - Iannone, F. AU - Cantini, F. AU - Lapadula, G. PY - 2014 DA - 2014// TI - Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations JO - J Rheumatol Suppl VL - 91 UR - https://doi.org/10.3899/jrheum.140101 DO - 10.3899/jrheum.140101 ID - Iannone2014 ER - TY - JOUR AU - Mobini, M. AU - Niksolat, F. AU - Ghasemian, R. AU - Sharifpour, A. AU - Valipour, S. PY - 2017 DA - 2017// TI - De novo tuberculosis during anti-tumor necrosis factor-alpha therapy in a rheumatoid arthritis patient with negative initial screening JO - J Mazandaran Univ Med Sci VL - 26 ID - Mobini2017 ER - TY - JOUR AU - Slouma, M. AU - Mahmoud, I. AU - Saidane, O. AU - Bouden, S. AU - Abdelmoula, L. PY - 2017 DA - 2017// TI - Latent tuberculosis infection screening prior to biological treatment in Tunisian patients JO - Therapies. VL - 72 UR - https://doi.org/10.1016/j.therap.2017.02.002 DO - 10.1016/j.therap.2017.02.002 ID - Slouma2017 ER - TY - JOUR AU - Park, J. H. AU - Seo, G. Y. AU - Lee, J. S. AU - Kim, T. -. H. AU - Yoo, D. -. H. PY - 2009 DA - 2009// TI - Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial JO - J Rheumatol VL - 36 UR - https://doi.org/10.3899/jrheum.090150 DO - 10.3899/jrheum.090150 ID - Park2009 ER - TY - JOUR AU - Cohn, D. L. AU - O’Brien, R. J. AU - Geiter, L. J. AU - Gordin, F. AU - Hershfield, E. AU - Horsburgh, C. PY - 2000 DA - 2000// TI - Targeted tuberculin testing and treatment of latent tuberculosis infection JO - MMWR Morb Mortal Wkly Rep VL - 49 ID - Cohn2000 ER - TY - JOUR AU - Nayak, S. AU - Acharjya, B. PY - 2012 DA - 2012// TI - Mantoux test and its interpretation JO - Indian Dermatol Online J VL - 3 UR - https://doi.org/10.4103/2229-5178.93479 DO - 10.4103/2229-5178.93479 ID - Nayak2012 ER - TY - JOUR AU - Pérez-Lu, J. E. AU - Cárcamo, C. P. AU - García, P. J. AU - Bussalleu, A. AU - Bernabé-Ortiz, A. PY - 2013 DA - 2013// TI - Tuberculin skin test conversion among health sciences students: a retrospective cohort study JO - Tuberculosis. VL - 93 UR - https://doi.org/10.1016/j.tube.2012.10.001 DO - 10.1016/j.tube.2012.10.001 ID - Pérez-Lu2013 ER - TY - JOUR AU - Murdaca, G. AU - Spanò, F. AU - Contatore, M. AU - Guastalla, A. AU - Penza, E. AU - Magnani, O. PY - 2015 DA - 2015// TI - Infection risk associated with anti-TNF-α agents: a review JO - Expert Opin Drug Saf VL - 14 UR - https://doi.org/10.1517/14740338.2015.1009036 DO - 10.1517/14740338.2015.1009036 ID - Murdaca2015 ER - TY - BOOK AU - Murdaca, G. AU - Colombo, B. M. AU - Puppo, F. PY - 2009 DA - 2009// TI - Anti-TNF-α inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events PB - SAGE Publications Sage UK CY - London, England UR - https://doi.org/10.1177/039463200902200301 DO - 10.1177/039463200902200301 ID - Murdaca2009 ER - TY - STD TI - Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F. Update Upon Efficacy and Safety of TNF-α Inhibitors. Expert Opin Drug Saf. 2012;11(1):1–5. ID - ref23 ER - TY - JOUR AU - Askling, J. AU - Fored, C. M. AU - Brandt, L. AU - Baecklund, E. AU - Bertilsson, L. AU - Cöster, L. PY - 2005 DA - 2005// TI - Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden JO - Arthritis Rheumatism VL - 52 UR - https://doi.org/10.1002/art.21137 DO - 10.1002/art.21137 ID - Askling2005 ER - TY - JOUR AU - Debeuckelaere, C. AU - Munter, P. AU - Bleyenbergh, P. AU - Wever, W. AU - Assche, G. AU - Rutgeerts, P. PY - 2014 DA - 2014// TI - Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening JO - J Crohn's Colitis VL - 8 UR - https://doi.org/10.1016/j.crohns.2013.11.008 DO - 10.1016/j.crohns.2013.11.008 ID - Debeuckelaere2014 ER - TY - JOUR AU - Byun, J. M. AU - Lee, C. K. AU - Rhee, S. Y. AU - Kim, H. -. J. AU - Kim, J. -. W. AU - Shim, J. -. J. PY - 2015 DA - 2015// TI - The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers JO - J Korean Med Sci VL - 30 UR - https://doi.org/10.3346/jkms.2015.30.2.173 DO - 10.3346/jkms.2015.30.2.173 ID - Byun2015 ER - TY - JOUR AU - Keane, J. AU - Gershon, S. AU - Wise, R. P. AU - Mirabile-Levens, E. AU - Kasznica, J. AU - Schwieterman, W. D. PY - 2001 DA - 2001// TI - Tuberculosis associated with infliximab, a tumor necrosis factor α–neutralizing agent JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011110 DO - 10.1056/NEJMoa011110 ID - Keane2001 ER - TY - JOUR AU - Bélard, E. AU - Semb, S. AU - Ruhwald, M. AU - Werlinrud, A. M. AU - Soborg, B. AU - Jensen, F. K. PY - 2011 DA - 2011// TI - Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection JO - Inflamm Bowel Dis VL - 17 UR - https://doi.org/10.1002/ibd.21605 DO - 10.1002/ibd.21605 ID - Bélard2011 ER - TY - JOUR AU - Kleinert, S. AU - Kurzai, O. AU - Elias, J. AU - Marten, K. AU - Engelke, C. AU - Feuchtenberger, M. PY - 2010 DA - 2010// TI - Comparison of two interferon-γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.113829 DO - 10.1136/ard.2009.113829 ID - Kleinert2010 ER - TY - JOUR AU - Gardam, M. A. AU - Keystone, E. C. AU - Menzies, R. AU - Manners, S. AU - Skamene, E. AU - Long, R. PY - 2003 DA - 2003// TI - Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management JO - Lancet Infect Dis VL - 3 UR - https://doi.org/10.1016/S1473-3099(03)00545-0 DO - 10.1016/S1473-3099(03)00545-0 ID - Gardam2003 ER - TY - JOUR AU - Giacomini, E. AU - Iona, E. AU - Ferroni, L. AU - Miettinen, M. AU - Fattorini, L. AU - Orefici, G. PY - 2001 DA - 2001// TI - Infection of human macrophages and dendritic cells with mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response JO - J Immunol VL - 166 UR - https://doi.org/10.4049/jimmunol.166.12.7033 DO - 10.4049/jimmunol.166.12.7033 ID - Giacomini2001 ER - TY - JOUR AU - Pfeffer, K. AU - Matsuyama, T. AU - Kündig, T. M. AU - Wakeham, A. AU - Kishihara, K. AU - Shahinian, A. PY - 1993 DA - 1993// TI - Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection JO - Cell. VL - 73 UR - https://doi.org/10.1016/0092-8674(93)90134-C DO - 10.1016/0092-8674(93)90134-C ID - Pfeffer1993 ER -